Sonoma Pharmaceuticals Inc (SNOA)
0.236
-0.01
(-5.60%)
USD |
NASDAQ |
May 17, 16:00
0.2495
+0.01
(+5.72%)
Pre-Market: 09:03
Sonoma Pharmaceuticals Enterprise Value: 1.321M for May 17, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 17, 2024 | 1.321M |
| May 16, 2024 | 1.540M |
| May 15, 2024 | -0.0209M |
| May 14, 2024 | 0.0025M |
| May 13, 2024 | -0.0209M |
| May 10, 2024 | -0.0911M |
| May 09, 2024 | 0.0556M |
| May 08, 2024 | -0.0131M |
| May 07, 2024 | -0.0193M |
| May 06, 2024 | 0.0072M |
| May 03, 2024 | 0.0728M |
| May 02, 2024 | 0.0275M |
| May 01, 2024 | 0.0291M |
| April 30, 2024 | 0.118M |
| April 29, 2024 | 0.1367M |
| April 26, 2024 | 0.1196M |
| April 25, 2024 | 0.1414M |
| April 24, 2024 | 0.1352M |
| April 23, 2024 | 0.1196M |
| April 22, 2024 | 0.0946M |
| April 19, 2024 | -0.0209M |
| April 18, 2024 | 0.0821M |
| April 17, 2024 | 0.2616M |
| April 16, 2024 | 0.2288M |
| April 15, 2024 | 0.157M |
| Date | Value |
|---|---|
| April 12, 2024 | 0.3771M |
| April 11, 2024 | 0.2585M |
| April 10, 2024 | 0.3287M |
| April 09, 2024 | 0.0759M |
| April 08, 2024 | -0.0693M |
| April 05, 2024 | 0.015M |
| April 04, 2024 | 0.1399M |
| April 03, 2024 | 0.104M |
| April 02, 2024 | -0.0989M |
| April 01, 2024 | 0.0291M |
| March 28, 2024 | 0.2335M |
| March 27, 2024 | 0.2148M |
| March 26, 2024 | 0.104M |
| March 25, 2024 | -0.177M |
| March 22, 2024 | -0.1614M |
| March 21, 2024 | -0.2706M |
| March 20, 2024 | -0.2269M |
| March 19, 2024 | -0.0989M |
| March 18, 2024 | -0.1926M |
| March 15, 2024 | -0.2191M |
| March 14, 2024 | -0.2566M |
| March 13, 2024 | -0.2238M |
| March 12, 2024 | -0.177M |
| March 11, 2024 | -0.0365M |
| March 08, 2024 | 0.0415M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-1.044M
Minimum
Oct 27 2023
17.73M
Maximum
Sep 28 2021
5.878M
Average
4.334M
Median
Dec 17 2019
Enterprise Value Benchmarks
| NovaBay Pharmaceuticals Inc | 5.156M |
| Palatin Technologies Inc | 22.26M |
| iBio Inc | 16.77M |
| Theriva Biologics Inc | -8.901M |
| Oragenics Inc | 8.862M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -0.866M |
| Revenue (Quarterly) | 3.138M |
| Total Expenses (Quarterly) | 3.982M |
| EPS Diluted (Quarterly) | -0.08 |
| Gross Profit Margin (Quarterly) | 46.53% |
| Profit Margin (Quarterly) | -27.60% |
| Earnings Yield | -398.3% |
| Normalized Earnings Yield | -398.31 |